A Short-Term Cost-of-Treatment Model for Type 2 Diabetes: Comparison of Glipizide Gastrointestinal Therapeutic System, Metformin, and Acarbose

August 1, 1999

Joe W. Ramsdell, MD, Joseph A. Grossman, MD, Jennifer M. Stevens, PharmD, Marc F. Botteman, MSc, MA, Raul Arocho, PhD

The American Journal of Managed Care, August 1999, Volume 5, Issue 8